{"id":"https://openalex.org/W2363987367","doi":null,"title":"A randomized double-blind controlled trial of bicyclol in treatment of chronic hepatitis B","display_name":"A randomized double-blind controlled trial of bicyclol in treatment of chronic hepatitis B","publication_year":2002,"publication_date":"2002-10-03","ids":{"openalex":"https://openalex.org/W2363987367","mag":"2363987367"},"language":"en","primary_location":{"id":"mag:2363987367","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYYL200208002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036848550","display_name":"Yao Bi","orcid":"https://orcid.org/0009-0007-9887-6770","observed_orcids":["https://orcid.org/0009-0007-9887-6770"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yao Bi","raw_affiliation_strings":["bi  1, JI Yan  yan  1, WANG Qin  huan  2, ZHOU Xia  qiu  3, XU Dao  zhen  4, CHEN Xin  yue  5, ZHANG Qin  bo  6"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bi  1, JI Yan  yan  1, WANG Qin  huan  2, ZHOU Xia  qiu  3, XU Dao  zhen  4, CHEN Xin  yue  5, ZHANG Qin  bo  6","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103006441","display_name":"J. Yan","orcid":"https://orcid.org/0000-0003-1142-7248","observed_orcids":["https://orcid.org/0000-0003-1142-7248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Yan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1142-7248","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053714875","display_name":"Wang Qin Huan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang Qin Huan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023098631","display_name":"Zhou Xia Qiu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhou Xia Qiu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017076590","display_name":"Xiaofeng Zhen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaofeng Zhen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101815528","display_name":"Yue Chen","orcid":"https://orcid.org/0000-0002-2940-9462","observed_orcids":["https://orcid.org/0000-0002-2940-9462"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yue Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2940-9462","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084844261","display_name":"Zhang Qin Bo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhang Qin Bo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4409,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.67312653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"21","issue":"8","first_page":"457","last_page":"462"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bicyclol","display_name":"bicyclol","score":0.972000002861023},{"id":"https://openalex.org/keywords/bifendate","display_name":"bifendate","score":0.9120000004768372},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/hbeag-seroconversion","display_name":"HBeAg seroconversion","score":0.9200000166893005},{"id":"https://openalex.org/keywords/hbv-dna-suppression","display_name":"HBV DNA suppression","score":0.7360000014305115},{"id":"https://openalex.org/keywords/alt-normalization","display_name":"ALT normalization","score":0.8299999833106995},{"id":"https://openalex.org/keywords/liver-function","display_name":"liver function","score":0.4020000100135803},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7490000128746033},{"id":"https://openalex.org/keywords/treatment-efficacy-comparison","display_name":"treatment efficacy comparison","score":0.4000000059604645},{"id":"https://openalex.org/keywords/hbeag-negative-chronic-hepatitis-b","display_name":"HBeAg-negative hepatitis B","score":0.49300000071525574},{"id":"https://openalex.org/keywords/hbeag-positive-chronic-hepatitis-b","display_name":"HBeAg-positive hepatitis B","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hepatitis-b-surface-antigen","display_name":"hepatitis B surface antigen","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8593368530273438},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6824257373809814},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6571002006530762},{"id":"https://openalex.org/C2775940106","wikidata":"https://www.wikidata.org/wiki/Q10478733","display_name":"HBeAg","level":5,"score":0.5675054788589478},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.4812576472759247},{"id":"https://openalex.org/C2992208098","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver function","level":2,"score":0.4601294696331024},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45536842942237854},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43550175428390503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4336647689342499},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.3260553479194641},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23288702964782715},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.16517841815948486},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.11217370629310608},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07854533195495605},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2363987367","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYYL200208002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2347961897","https://openalex.org/W2364937807","https://openalex.org/W2374522139","https://openalex.org/W1893065545","https://openalex.org/W2352407028","https://openalex.org/W2382192228","https://openalex.org/W2349198217","https://openalex.org/W2411781968","https://openalex.org/W2358946327","https://openalex.org/W2354557701"],"abstract_inverted_index":{"AIM:":[0],"To":[1,74],"evaluate":[2],"the":[3,26,158,185,206,212,317,406,409,423,437],"efficacy":[4],"and":[5,22,47,65,87,90,93,100,114,127,132,138,145,160,167,173,176,193,219,232,236,242,245,263,269,274,288,321,352,369,374,382,388,392,412,415,428,434],"safety":[6,66,435],"of":[7,28,32,125,153,184,190,214,221,250,282,308,311,329,364,390,408,425,439],"bicyclol":[8,20,35,109,210,287,335,365],"for":[9,41,405],"chronic":[10],"hepatits":[11],"B(CHB).":[12],"METHODS:":[13],"CHB":[14],"patients":[15,33,298],"were":[16,82,103,119,129,164,227,258,303,331,343,367,376],"randomly":[17],"divided":[18],"into":[19],"group":[21,24,31,211,336,366],"bifendate":[23,37,81,156,254,289,340,421],"on":[25,72,422],"ratio":[27],"2\u22361.":[29],"Each":[30],"received":[34,399],"or":[36,80],"2":[38],"mg":[39],"tid":[40],"24":[42,226],"wk,":[43],"then":[44,237],"stopped":[45],"treatment":[46,330],"followed":[48],"up":[49],"12":[50,149,180,246,278,325,356],"wk.":[51],"Investigating":[52],"items":[53],"included":[54],"clinical":[55,112,410],"symptoms,":[56],"liver":[57],"function":[58],"tests,":[59],"serum":[60,115,191,413,426],"hepatitis":[61],"B":[62],"(HBV)":[63],"markers":[64],"profile.":[67],"Efficacy":[68],"evaluation":[69],"was":[70],"based":[71],"Intent":[73],"Treat":[75],"(ITT)":[76],"principle.":[77],"RESULTS:":[78],"Bicyclol":[79,402,417],"given":[83],"to":[84,420],"two":[85,200,387],"hundred":[86,92],"sixty":[88],"nine":[89],"one":[91,379,396],"thirty":[94],"eight":[95],"patients,":[96],"respectively.":[97,187],"The":[98,122,188,361],"demographic":[99],"baseline":[101,300],"features":[102],"similar":[104],"in":[105,142,209,253,297,334,339,378,386,395],"both":[106,111],"groups.":[107],"After":[108],"therapy,":[110],"symptoms":[113,411],"ALT,":[116],"AST":[117,128,161,194],"levels":[118,302],"improved":[120],"markedly.":[121],"normalization":[123,162],"rates":[124,163,320,323],"ALT":[126,159,192,301,414],"53.5":[130],"%":[131,134,144,147,166,169,175,178,229,231,241,244,262,265,273,276,345,354,357],"48.7":[133,146],"at":[135,148,170,179,224,266,277,324],"wk":[136,150,171,181,225,247,267,279,326],"24,":[137,172,268],"kept":[139],"sustained":[140],"normal":[141,312],"40.2":[143],"after":[151,182,248,280,327],"stop":[152,183,249,281,328],"treatment.":[154,251,283],"In":[155],"group,":[157,255,341],"61.6":[165],"44.2":[168],"45.7":[174,243],"50.0":[177],"treatment,":[186],"improvement":[189,407],"showed":[195,291],"no":[196,292],"statistical":[197,294],"difference":[198],"between":[199,286],"groups":[201,290],"(":[202,358],"P":[203,349,359],"0.05).":[204],"Regarding":[205],"HBV":[207,222],"markers,":[208],"negativity":[213,220],"HBeAg,":[215],"HBeAg/Anti":[216],"HBe":[217],"seroconversion":[218,322],"DNA":[223],"20.8":[228,240],"15.6":[230],"39.0":[233],"%,":[234,239,260,271],"respectively,":[235],"29.0":[238],"Whereas":[252],"those":[256,338,342],"parameters":[257],"15.2":[259],"9.4":[261],"37.7":[264],"21.0":[270],"14.5":[272],"38.4":[275],"These":[284],"results":[285],"significant":[293,332],"difference.":[295],"However,":[296],"whose":[299],"higher":[304,333],"than":[305,337],"5":[306],"times":[307],"upper":[309],"limit":[310],"(200":[313],"U\u00b7L":[314],"-1":[315],"),":[316],"HBeAg":[318,427],"negative":[319],"48":[344],"versus":[346,355],"22":[347],"%(":[348],"=":[350],"0.015)":[351],"38":[353],"=0.01).":[360],"adverse":[362],"reactions":[363],"mild":[368],"uncommon,":[370],"only":[371],"skin":[372,383],"rash":[373],"dizzeness":[375],"occurred":[377,385,394],"patient":[380,397],"each;":[381],"rashes":[384],"loss":[389],"appetite":[391],"nausea":[393],"who":[398],"bifendate.":[400],"CONCLUSION:":[401],"is":[403,418,431],"effective":[404],"AST.":[416],"superior":[419],"clearance":[424],"seroconversion.":[429],"It":[430],"well":[432],"tolerated":[433],"throughout":[436],"course":[438],"trial.":[440]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}